Competitor Research

Startup awarded nearly $1M to advance diabetes drug

New treatments for the 1.6 million Americans with type 1 diabetes have remained frustratingly elusive for drug developers, but Neurodon classifies its potential drug as “game-changing.” The startup, based in the Purdue Research Park of Northwest Indiana, is confident it’s uncovered a new treatment that could reduce insulin dependency for millions of Americans. Neurodon says …

Startup awarded nearly $1M to advance diabetes drug Read More »